Chinese english Germany Japanese Korea

N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine

N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Struktur
930039-92-2
CAS-Nr.
930039-92-2
Englisch Name:
N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
Synonyma:
BRD4 Inhibitor-27;BRD4u00A0Inhibitor-27;N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;1,2,4-Triazolo[4,3-b]pyridazin-6-amine, N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-
CBNumber:
CB14594461
Summenformel:
C16H13F3N6
Molgewicht:
346.31
MOL-Datei:
930039-92-2.mol
Request For Quotation

N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Eigenschaften

Dichte
1.54±0.1 g/cm3(Predicted)
pka
17.14±0.30(Predicted)

Sicherheit

N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Chemische Eigenschaften,Einsatz,Produktion Methoden

N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720
 klq@cw-bio.com China 4192 55
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 24647 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
 customer_service@efebio.com China 11975 58
Nantong Hanfang Biotechnology Co. , Ltd. 18616537568
 hanfangpharma@126.com China 30968 58
  • N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
  • 1,2,4-Triazolo[4,3-b]pyridazin-6-amine, N-[2-(1H-indol-3-yl)ethyl]-3-(trifluoromethyl)-
  • BRD4 Inhibitor-27
  • BRD4u00A0Inhibitor-27
  • 930039-92-2
Copyright 2019 © ChemicalBook. All rights reserved